Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF (SUPPORT-AF)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03583008|
Recruitment Status : Completed
First Posted : July 11, 2018
Last Update Posted : March 21, 2019
|Condition or disease||Intervention/treatment||Phase|
|Atrial Fibrillation Prescribing Practices Anticoagulants||Behavioral: Anticoagulation (AC) Intervention--Academic Detailing Behavioral: Anticoagulation (AC) Intervention--Prescribing Practices||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||112 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF|
|Actual Study Start Date :||June 11, 2018|
|Actual Primary Completion Date :||February 1, 2019|
|Actual Study Completion Date :||March 1, 2019|
Experimental: Anticoagulation (AC) Intervention
Providers in this arm will receive supportive tools including Anticoagulation (AC) Intervention--Prescribing Practices and Anticoagulation (AC) Intervention--Academic Detailing to help them assess their Anticoagulant (AC) prescribing practices and will also meet with the study investigators for academic detailing.
Behavioral: Anticoagulation (AC) Intervention--Academic Detailing
One hour online web-based academic detailing session to develop an anticoagulant (AC) learning plan.
Behavioral: Anticoagulation (AC) Intervention--Prescribing Practices
Education and support related to anticoagulant prescribing practices.
No Intervention: Control
Providers in this arm will not receive any intervention.
- Change to Provider prescription rates [ Time Frame: Intervention to three months post intervention. ]The first primary outcome measure is to determine the impact of the intervention on provider prescribing rates (increase, decrease, same)
- Change to Individual patient Anticoagulation (AC) status [ Time Frame: Intervention to three months post intervention. ]The effect of the intervention on individual patient anti-coagulation status as demonstrated by random effects logistic regression models for post-intervention AC status (anticoagulated / not anticoagulated) as a function of pre-intervention AC status.
- Change in provider confidence in applying evidence to balance stroke prevention with harm. [ Time Frame: Intervention to three months post intervention. ]The change in provide confidence as assessed by confidence questions included in the provider survey distributed with the AC Provider Profile. More specifically, the change is calculated with an average score for each item in the confidence survey, using a four-point scale based on four response choices - not confident through very confident.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03583008
|United States, Massachusetts|
|UMass Medical School|
|Worcester, Massachusetts, United States, 01566|
|Principal Investigator:||Alok Kapoor, MD, MSca||UMass Medical School|